Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Mei-Ti Wang"'
Autor:
Shun-Xian Zhang, Feng-Yu Miao, Jian Yang, Wen-Ting Zhou, Shan Lv, Fan-Na Wei, Yu Wang, Xiao-Jie Hu, Ping Yin, Pei-Yong Zheng, Ming Yang, Mei-Ti Wang, Xin-Yu Feng, Lei Duan, Guo-Bing Yang, Ji-Chun Wang, Zhen-Hui Lu
Publikováno v:
Infectious Diseases of Poverty, Vol 13, Iss 1, Pp 1-21 (2024)
Abstract Background Tuberculosis (TB) is a major infectious disease with significant public health implications. Its widespread transmission, prolonged treatment duration, notable side effects, and high mortality rate pose severe challenges. This stu
Externí odkaz:
https://doaj.org/article/7fcd1a9619fc476b8d502988eb701cba
Autor:
Mei-Ti Wang, 王美迪
89
The therapeutic efficacy of hypoxia-inducible factor-1 (HIF-1) transcriptional regulatory system for ischemic hindlimb has been demonstrated. It is not known whether this transcriptional regulatory system can be used as a therapeutic strategy
The therapeutic efficacy of hypoxia-inducible factor-1 (HIF-1) transcriptional regulatory system for ischemic hindlimb has been demonstrated. It is not known whether this transcriptional regulatory system can be used as a therapeutic strategy
Externí odkaz:
http://ndltd.ncl.edu.tw/handle/32147121461053060210
Publikováno v:
CNS Neuroscience & Therapeutics. 24:572-574
Publikováno v:
Oncology Letters
Chemotherapeutic agents can result in extravasation, which is considered to be a serious complication. The increasing number of exposures to different cytotoxic agents experienced by each patient may enhance the prevalence of this complication. Docet
Autor:
Jyh Gang Leu, Chih Chuna Chang, Kou Gi Shyu, Peiliang Kuan, Bao Wei Wang, Hang Chang, Mei Ti Wang
Publikováno v:
Cardiovascular research. 54(3)
The therapeutic utility of hypoxia-inducible factor-1 (HIF-1) transcriptional regulatory system for ischemic hindlimb has been demonstrated. It is not yet known whether this transcriptional regulatory system can be used as a therapeutic strategy to e
Autor:
PEI-HUNG CHANG1, MEI-TI WANG2, YI-HUA CHEN2, YU-YING CHEN2, CHENG-HSU WANG1,3 ph555chang@gmail.com
Publikováno v:
Oncology Letters. 2014, Vol. 7 Issue 5, p1497-1498. 2p.